Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma.

Zhu QQ, Wang ZQ, Zhu WR, Chen WX, Wu JT.

Acta Radiol. 2013 Apr 1;54(3):355-62. doi: 10.1258/ar.2012.120255. Epub 2013 Feb 27.

PMID:
23446748
2.

MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.

Woo S, Kim SY, Lee MS, Moon KC, Kim SH, Cho JY, Kim SH.

AJR Am J Roentgenol. 2015 Mar;204(3):542-9. doi: 10.2214/AJR.14.12950.

PMID:
25714283
3.
4.

Dynamic Computed Tomographic Features of Adult Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene Fusions: Comparison With Clear Cell Renal Cell Carcinoma.

He J, Gan W, Liu S, Zhou K, Zhang G, Guo H, Zhu B.

J Comput Assist Tomogr. 2015 Sep-Oct;39(5):730-6. doi: 10.1097/RCT.0000000000000263.

PMID:
25955396
5.

TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.

Rao Q, Williamson SR, Zhang S, Eble JN, Grignon DJ, Wang M, Zhou XJ, Huang W, Tan PH, Maclennan GT, Cheng L.

Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.

PMID:
23598965
6.

Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.

Argani P, Olgac S, Tickoo SK, Goldfischer M, Moch H, Chan DY, Eble JN, Bonsib SM, Jimeno M, Lloreta J, Billis A, Hicks J, De Marzo AM, Reuter VE, Ladanyi M.

Am J Surg Pathol. 2007 Aug;31(8):1149-60.

PMID:
17667536
7.

[Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].

Rao Q, Zhou J, Zhang RS, Ma HH, Zhou HB, Lu ZF, Zhou XJ.

Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):582-6. Chinese.

PMID:
21092583
8.

Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.

Wang W, Ding J, Li Y, Wang C, Zhou L, Zhu H, Peng W.

PLoS One. 2014 Jun 13;9(6):e99990. doi: 10.1371/journal.pone.0099990. eCollection 2014.

9.

Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients.

Chen X, Zhu Q, Li B, Cui W, Zhou H, Duan N, Liu Y, Kundra V, Wang Z.

Eur Radiol. 2016 Jun 2. [Epub ahead of print]

PMID:
27255396
10.

Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas.

He J, Zhou K, Zhu B, Zhang G, Li X, Guo H, Gan W, Zhou Z, Liu T.

Biomed Res Int. 2015;2015:298679. doi: 10.1155/2015/298679. Epub 2015 Nov 9.

11.

Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.

Argani P, Hicks J, De Marzo AM, Albadine R, Illei PB, Ladanyi M, Reuter VE, Netto GJ.

Am J Surg Pathol. 2010 Sep;34(9):1295-303. doi: 10.1097/PAS.0b013e3181e8ce5b.

12.

The MSCT and MRI findings of collecting duct carcinoma.

Zhu Q, Wu J, Wang Z, Zhu W, Chen W, Wang S.

Clin Radiol. 2013 Oct;68(10):1002-7. doi: 10.1016/j.crad.2013.04.004. Epub 2013 May 28.

PMID:
23726725
13.

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

Green WM, Yonescu R, Morsberger L, Morris K, Netto GJ, Epstein JI, Illei PB, Allaf M, Ladanyi M, Griffin CA, Argani P.

Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.

PMID:
23715164
14.

XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.

Hung CC, Pan CC, Lin CC, Lin AT, Chen KK, Chang YH.

J Chin Med Assoc. 2011 Nov;74(11):500-4. doi: 10.1016/j.jcma.2011.09.005. Epub 2011 Nov 1.

15.

Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.

Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, de Martino M, Waldert M, Marberger M, Susani M, Haitel A.

Am J Clin Pathol. 2012 May;137(5):761-8. doi: 10.1309/AJCPQ6LLFMC4OXGC.

16.

Radiologic-pathologic correlation of renal cell carcinoma associated with Xp11.2 translocation.

Koo HJ, Choi HJ, Kim MH, Cho KS.

Acta Radiol. 2013 Sep;54(7):827-34. doi: 10.1177/0284185113484019. Epub 2013 May 9.

PMID:
23761541
17.

Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype.

Kato H, Kanematsu M, Yokoi S, Miwa K, Horie K, Deguchi T, Hirose Y.

J Magn Reson Imaging. 2011 Jan;33(1):217-20. doi: 10.1002/jmri.22392.

PMID:
21182142
18.

Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.

Komai Y, Fujiwara M, Fujii Y, Mukai H, Yonese J, Kawakami S, Yamamoto S, Migita T, Ishikawa Y, Kurata M, Nakamura T, Fukui I.

Clin Cancer Res. 2009 Feb 15;15(4):1170-6. doi: 10.1158/1078-0432.CCR-08-1183.

19.

Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions: findings on MRI and computed tomography imaging.

Liu K, Xie P, Peng W, Zhou Z.

J Magn Reson Imaging. 2014 Aug;40(2):440-7. doi: 10.1002/jmri.24349. Epub 2013 Oct 17.

PMID:
24136829
20.

Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.

Mosquera JM, Dal Cin P, Mertz KD, Perner S, Davis IJ, Fisher DE, Rubin MA, Hirsch MS.

Diagn Mol Pathol. 2011 Sep;20(3):129-37. doi: 10.1097/PDM.0b013e31820e9c67.

PMID:
21817901
Items per page

Supplemental Content

Write to the Help Desk